Showing results (241-250 of 250) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Pharmacotherapy|January 1, 1992
Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysisD Kremer, M Y Munar, S J Kohlhepp, et al.Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.Kidney International|August 1, 1995
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicityB A Young, E A Burdmann, R J Johnson, et al.Clinical Transplants|January 1, 1996
Thirty-seven years of renal transplantation in OregonJ M Barry, M J Lemmers, M J Conlin, et al.Transplantation|December 1, 1993
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicityS R Smith, V B Kubacki, A Rakhit, et al.The Journal of Infectious Diseases|July 1, 1988
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscessC A Wood, D R Norton, S J Kohlhepp, et al.Clinical Pharmacology and Therapeutics|March 1, 1991
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter studyM Moser, P A Abraham, W M Bennett, et al.Journal of the American Society of Nephrology : JASN|October 1, 1995
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontinR H Pichler, N Franceschini, B A Young, et al.Kidney International|December 1, 1996
SPARC is expressed in renal interstitial fibrosis and in renal vascular injuryR H Pichler, C Hugo, S J Shankland, et al.JAMA|February 24, 2001
Consensus statement on the live organ donorM Abecassis, M Adams, P Adams, et al.Pageof 25